Back to Seven Fleet Capital Management LP

Seven Fleet Capital Management LP

All holdings · as of Dec 31, 2025

85 positions

CompanyClassValueShares% of portfolio
TARSUS PHARMACEUTICALS, INC.$368.5K4,5000.3%
PLIANT THERAPEUTICS, INC.PLRXCommon Stock$337.3K276,5000.3%
Aclaris Therapeutics, Inc.$323.3K107,4190.2%
Septerna, Inc.SEPNCommon Stock$319.1K11,4450.2%
Climb Bio, Inc.CLYMCommon Stock$305.6K76,4000.2%
COMPASS Pathways plcCMPSADR$276.0K40,0000.2%
ENTERA BIO LTD$262.5K135,3180.2%
Viking Therapeutics Inc$211.1K6,0000.2%
UNIQURE NV$209.2K8,7420.2%
CytomX Therapeutics, Inc.$208.3K48,8980.2%
Ocular Therapeutix, Inc$207.6K17,1000.2%
Enliven Therapeutics, Inc.ELVNCommon Stock$180.0K11,6880.1%
Oruka Therapeutics, Inc.$158.8K5,2400.1%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$146.8K4,3150.1%
NEWAMSTERDAM PHARMA COMPANY$140.3K4,0000.1%
Amylyx Pharmaceuticals, Inc.$139.8K11,5710.1%
Apogee Therapeutics, Inc.$135.9K1,8000.1%
ALX Oncology Holdings Inc.$133.1K117,8170.1%
Verastem, Inc.$116.9K15,1400.1%
REGENCELL BIOSCIENCE HLDGS L$92.4K4,4000.1%
Trevi Therapeutics, Inc.$89.0K7,1100.1%
Immunic, Inc.$82.8K155,2230.1%
PMV Pharmaceuticals, Inc.PMVPCommon Stock$79.4K63,4980.1%
Monte Rosa Therapeutics, Inc.$62.7K4,0000.0%
Traws Pharma, Inc.$55.7K49,2600.0%
ASTRIA THERAPEUTICS INC$52.4K4,0000.0%
Edgewise Therapeutics, Inc.$49.6K2,0000.0%
Vistagen Therapeutics, Inc.VTGNCommon Stock$41.5K62,7010.0%
ENANTA PHARMACEUTICALS INC$35.8K2,2700.0%
Cullinan Therapeutics, Inc.$31.1K3,0000.0%
GENERATION BIO CO$30.5K5,3760.0%
Beam Therapeutics Inc.$9.3K3370.0%
Eledon Pharmaceuticals, Inc.$9.1K6,0000.0%
ABIVAX SA$1.6K120.0%
Vir Biotechnology, Inc.$1.2K2000.0%
← PrevPage 2 of 2Next →